Case Report: From misdiagnosis to successful treatment using mepolizumab in ANCA-negative severe EGPA—clinical lessons in eosinophil-targeted therapy - Top-Institutions - MDSpire

Case Report: From misdiagnosis to successful treatment using mepolizumab in ANCA-negative severe EGPA—clinical lessons in eosinophil-targeted therapy

  • By

  • Ju-Zhang Li

  • Si-Yao Guan

  • Qiao-Zhen Wu

  • Jiang-Nan Zheng

  • July 8, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    The Johns Hopkins Hospital
    The Johns Hopkins Hospital

    Baltimore, Maryland

    Key Differentiators

    • Rheumatology
    • Allergy and Immunology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Rheumatology
    • Allergy and Immunology

  • #3

    IRCCS Ospedale San Raffaele
    IRCCS Ospedale San Raffaele

    Milan, Italy

    Key Differentiators

    • Allergy and Immunology

  • #4

    Amsterdam University Medical Center
    Amsterdam University Medical Center

    Amsterdam, Netherlands

    Key Differentiators

    • Allergy and Immunology

  • #5

    University of Michigan
    University of Michigan

    Ann Arbor, Michigan

    Key Differentiators

    • Gastroenterology
    • Allergy and Immunology

Original Source(s)

Case Report: From misdiagnosis to successful treatment using mepolizumab in ANCA-negative severe EGPA—clinical lessons in eosinophil-targeted therapy

  • by Ju-Zhang Li, Si-Yao Guan, Qiao-Zhen Wu, Jiang-Nan Zheng

  • July 8, 2026

Related Content

Genistein in autoimmune diseases: from experimental evidence to emerging clinical data

Efficacy and Safety of Rituximab in Pemphigus Foliaceus: A Systematic Review and Meta-analysis

Osteoarthritis as a systemic disorder: multi-organ crosstalk in pathogenesis and therapeutic targeting